Status and phase
Conditions
Treatments
About
Open, multicenter, non randomized, single arm, pilot trial.
Full description
Open, multicenter, non randomized, single arm, pilot trial. The study is aimed at patients infected with HIV in triple antiretroviral therapy based on Dolutegravir (DTG) who experience neuropsychological adverse effects related to the treatment. After signing the informed consent, DTG will be replaced by Raltegravir (RAL) 1200 QD, maintaining the other two drugs that constituted the triple therapy established before the inclusion of the patient in the study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Additional Exclusion Criteria (for patients recruited at the Costa del Sol Hospital in Marbella only):
Primary purpose
Allocation
Interventional model
Masking
50 participants in 1 patient group
Loading...
Central trial contact
Gloria Luque; Alejandro Pérez
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal